#007: Daniel Ives (Shift Bioscience) - April 1st, 2021

Update: 2021-04-01

Description

Daniel Ives is the founder and CEO of Shift Bioscience, an early-stage longevity biotechnology company developing anti-aging drugs based on mitochondrial pathways and a single-cell epigenetics discovery platform.

Comments

In Channel

#020: Daniel Oliver (Rejuvenate Bio) - July 21, 2021

2021-07-2101:12:09

#019: Future of Longevity II (George Church, Nir Barzilai, Kristen Fortney, Jim Mellon, Alejandro Ocampo, Jay Olshansky) - July 14th, 2021

2021-07-1401:20:15

#018: Anil Bhushan (Deciduous Therapeutics) - July 1st, 2021

2021-07-0101:05:18

#017: Longevity Panel: The scientists working on reversing aging - June 15th, 2021

2021-06-1602:06:15

#016: Sebastian Brunemeier (ex Apollo Health Ventures, co-founder Cambrian Biopharma) - June 10th, 2021

2021-06-1001:14:45

#015: Marinna Madrid (Cellino) - June 3rd, 2021

2021-06-0301:04:42

#014: Tyler Golato (VitaDAO) - May 27th, 2021

2021-05-2701:01:13

#013: Marco Quarta (Rubedo Life Sciences) - May 20th, 2021

2021-05-2101:05:36

#012: Matthew Scholz (Oisin Biotechnologies) - May 6th, 2021

2021-05-0601:14:36

#011: Kristen Fortney (BioAge Labs) - April 29th, 2021

2021-04-2901:03:08

#010: Jean Hebert (Albert Einstein College of Medicine, "Replacing Aging") - April 22nd, 2021

2021-04-2202:08:37

#009: Keshav Singh & Greg Schmerge (Yuva Biosciences) - April 15th, 2021

2021-04-1501:22:20

#008: Marc Bernegger, Tobias Reichmuth, Collin Ewald (Maximon) - April 8th, 2021

2021-04-0801:31:18

#007: Daniel Ives (Shift Bioscience) - April 1st, 2021

2021-04-0103:00:30

00:00

#007: Daniel Ives (Shift Bioscience) - April 1st, 2021

The Longevity Biotech Show

#box-pro-ellipsis-175929985679687{-webkit-line-clamp:2;}#007: Daniel Ives (Shift Bioscience) - April 1st, 2021

#007: Daniel Ives (Shift Bioscience) - April 1st, 2021

The Longevity Biotech Show

#007: Daniel Ives (Shift Bioscience) - April 1st, 2021